4.6 Article

Enzymatic redesigning of biologically active heparan sulfate

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 280, 期 52, 页码 42817-42825

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M504338200

关键词

-

资金

  1. NHLBI NIH HHS [HL52622, R01 HL052622, R01 HL062244-05A1, R01 HL062244] Funding Source: Medline
  2. NIAID NIH HHS [AI50050, R01 AI050050] Funding Source: Medline
  3. NIGMS NIH HHS [GM069968, R01 GM038060, R01 GM038060-16A2, GM38060, R01 GM069968, R01 GM038060-17] Funding Source: Medline

向作者/读者索取更多资源

Heparan sulfate carries a wide range of biological activities, regulating blood coagulation, cell differentiation, and inflammatory responses. The sulfation patterns of the polysaccharide are essential for the biological activities. In this study, we report an enzymatic method for the sulfation of multimilligram amounts of heparan sulfate with specific functions using immobilized sulfotransferases combined with a 3'-phosphoadenosine 5'-phosphosulfate regeneration system. By selecting appropriate enzymatic modification steps, an inactive precursor has been converted to the heparan sulfate having three distinct biological activities, associated with binding to antithrombin, fibroblast growth factor-2, and herpes simplex virus envelope glycoprotein D. Because the recombinant sulfotransferases are expressed in bacteria, and the method uses a low cost sulfo donor, it can be readily utilized to synthesize large quantities of anticoagulant heparin drug or other biologically active heparan sulfates.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据